These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 580990)

  • 1. Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds.
    Geratz JD; Tidwell RR; Brinkhous KM; Mohammad SF; Dann O; Loewe H
    Thromb Haemost; 1978 Apr; 39(2):411-25. PubMed ID: 580990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    Mills DC; Hunchak K; Karl DW; Kirby EP
    Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evans blue: a specific inhibitor of factor VIII-induced platelet agglutination.
    Kirby EP
    Thromb Diath Haemorrh; 1975 Dec; 34(3):770-9. PubMed ID: 1239827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of bovine factor VIII with human platelets.
    Kirby EP; Mills DC
    J Clin Invest; 1975 Aug; 56(2):491-502. PubMed ID: 807600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregation.
    Klein K; Sinzinger H; Silberbauer K; Stachelberger H; Leithner C
    Artery; 1980; 8(5):410-5. PubMed ID: 6783013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of Fc-receptor dependent platelet aggregation by monoclonal antibodies against the glycoprotein IIb-IIIa complex].
    Vinogradov DV; Vlasik TN; Agafonova OG; Vasil'ev SA; Lagutina NIa; Makarov VA; Berndt M; Mazurov AV
    Biokhimiia; 1991 May; 56(5):787-97. PubMed ID: 1747408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of trifluoperazine on aggregation of human platelets.
    Kindness G; Williamson FB; Long WF
    Thromb Res; 1980 Feb 1-15; 17(3-4):549-54. PubMed ID: 6768164
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro inhibition of platelet function and coagulation by pentamidine isethionate.
    Kempin SJ; Jackson CW; Edwards CC
    Antimicrob Agents Chemother; 1977 Oct; 12(4):451-4. PubMed ID: 921238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.